Pancreatic Cancer Research

ResearcherKumamoto UniversityActive in the last 2 years

Kosuke Mima

Matched on ORCID iD 0000-0002-4385-4984; OpenAlex author ID A5035573322. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: 4 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Cancer Resection. Co-author DOI 10.1002/jhbp.70032↗
  2. Molecular Alterations Influencing the Prognostic Outcome in Small Pancreatic Cancer (≤2 cm). Co-author DOI 10.1097/mpa.0000000000002430↗
  3. Impairment of perioperative activities of daily living is associated with poor prognosis following pancreatectomy for pancreatic cancer. First author DOI 10.1007/s00423-024-03478-7↗
  4. Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis… Co-author DOI 10.1038/s41416-022-02106-9↗
  5. The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. Co-author DOI 10.1097/mpa.0000000000002210↗
  6. Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer. Co-author DOI 10.1172/jci.insight.163022↗
  7. Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune suppression by downregulating PD-L1 exp… Co-author PMID 37293171↗
  8. Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2022.101533↗
  9. High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with Pancreatic Cancer: A Retrospective Study. Co-author DOI 10.1245/s10434-022-11500-9↗
  10. Frailty is associated with poor prognosis after resection for pancreatic cancer. Co-author DOI 10.1007/s10147-021-01983-z↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiromitsu Hayashi · 10 shared papers, 2021–2026 · strength 1.73
  2. Shigeki Nakagawa · 8 shared papers, 2021–2025 · strength 1.33
  3. Zhao Liu · 6 shared papers, 2022–2026 · strength 1.04
  4. Katsunori Imai · 6 shared papers, 2021–2023 · strength 0.84
  5. Takayoshi Kaida · 5 shared papers, 2021–2024 · strength 0.76
  6. Norio Uemura · 5 shared papers, 2021–2023 · strength 0.69
  7. Hideo Baba · 4 shared papers, 2022–2023 · strength 0.59
  8. Kazuki Matsumura · 4 shared papers, 2021–2023 · strength 0.56
  9. Takashi Matsumoto · 3 shared papers, 2021–2026 · strength 0.53
  10. Yuki Kitano · 2 shared papers, 2025–2026 · strength 0.52
  11. Toru Takematsu · 2 shared papers, 2025–2026 · strength 0.52
  12. Hirohisa Okabe · 2 shared papers, 2024–2026 · strength 0.49
  13. Rumi Itoyama · 3 shared papers, 2021–2024 · strength 0.45
  14. Hiroki Sato · 3 shared papers, 2022–2023 · strength 0.45
  15. Fumimasa Kitamura · 3 shared papers, 2021–2023 · strength 0.37
  16. Yosuke Nakao · 2 shared papers, 2021–2025 · strength 0.36
  17. Tatsunori Miyata · 2 shared papers, 2023 · strength 0.32
  18. Chuan Lan · 2 shared papers, 2022–2023 · strength 0.31
  19. Hideo Baba · 2 shared papers, 2022–2023 · strength 0.30
  20. Shinsei Yumoto · 1 shared paper, 2026 · strength 0.28
  21. Masaaki Iwatsuki · 1 shared paper, 2026 · strength 0.28
  22. Hideo Andreas Baba · 1 shared paper, 2025 · strength 0.25
  23. Takanobu Yamao · 1 shared paper, 2025 · strength 0.25
  24. Takashi Ofuchi · 1 shared paper, 2024 · strength 0.21
  25. Yuki Adachi · 1 shared paper, 2024 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.